FGF1 and neoplasm: Using these data, we analyzed responses to AZD4547 based on the mRNA expression of FGFs (FGF1–23) and FGFRs (FGFR1–4) in EOC patient tumor samples to test for the possible role of these genes as predictive biomarkers for AZD4547.